Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
This intro points out equity indices that qualify as total return and explains how dividends affect performance reporting.
24,588 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
SoftBank CEO Masayoshi Son says global AI demand will need roughly $5 trillion each year to scale infrastructure, arg...
Netflix just posted a record quarterly revenue, but the forecast for the next quarter came in softer than expected. H...
Institutional landlords are stepping up the sale of single-family rentals as the ROAD Act takes effect. Early data sh...
In a striking contrast, Nancy Pelosi buys bullish calls on Amazon as Berkshire Hathaway scales back its Amazon exposu...
GLPI's Q4 2025 results show growth, margin trends, and clearer guidance for 2026. This analysis translates the number...
Polestar faces a pivotal period as it refines profitability and expansion amid a crowded EV field. This report outlin...
An Oppenheimer upgrade follows Oracle’s dramatic price drop, suggesting patient investors could access a premier grow...
The U.S. and Israel launched airstrikes on Iran after weeks of buildup, triggering immediate market volatility. Oil, ...
SoFi shares jump after Anthony Noto buys $1 million in stock, a move traders say signals backing the growth plan. The...
Copper prices still surging have attracted buyers to the United States Copper Index Fund (CPER), a futures-based ETF....
Hims & Hers Health shares surged in premarket trading after reports they ended a dispute with Novo Nordisk by forging...